Gelteq Limited GELS
0.28 USD +0.01 (+3.93%)
As ofNov 19, 2026, 3:59 PM EST
0.28 Day range 0.2998
0.26 52-week range 2.01
- YTD
- -64.93%
- 1 year
- -69.23%
5D -0.1350 (-32.93%)
- Market cap
- 3.23M
- Revenue (ttm)
- 131.76K
- EPS (ttm)
- -0.44
- Shares out
- 9.44M
- YTD return
- -64.93%
- 1-year return
- -69.23%
- Volume
- 10.87K
- Avg volume
- 2.85M
- Open
- 0.29
- Previous close
- 0.27
- Day's range
- 0.28 – 0.2998
- 52-week range
- 0.26 – 2.01
Key statistics
- 50-day average
- 2.45
- 200-day average
- 2.45
- Enterprise value
- 15.48M
- Price / sales
- 174.07
- Price / book
- 1.21
- Revenue growth
- -68.90%
- Free cash flow
- -463.50K
- Total cash
- 399.22K
- Total debt
- 2.49M
- Return on equity
- -18.75%
Fundamental scorecard
1 of 25 checks passed on GELS’s reported financials
1of 25 checks passed
- Value 0 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Jun 30, 2026.
Financials — quick view
GELS Revenue — quarterly 0
GELS Net income — quarterly -1.13M
About Gelteq Limited
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Australia
- Website
- gelteq.com
News
Your note
Sign in to keep a note on GELS — it syncs with the Stock Master app.
